Today’s Top Stories- March 1, 2018

0
300
breaking news

Is This Stock On Your Watch-List?

Investors’ attention is focused on this company as its device has been approved for the FDA’s Expedited Access Pathway (EAP) program. Since the start of clinical trials for its life saving device, we have seen a steady increase in trading volume. Momentum continues to build as the company becomes closer to possible FDA approval & we have the full details!

FULL DETAILS HERE!

LEAVE A REPLY

Please enter your comment!
Please enter your name here